Breaking News
November 20, 2018 - Towards finding a druggable cancer target
November 20, 2018 - Ultragenyx Announces Intent to Submit New Drug Application to U.S. FDA for UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Mid-2019
November 20, 2018 - Cooling ‘brains on fire’ to treat Parkinson’s
November 20, 2018 - Less pollution could increase the average lifespan of Copenhageners by an entire year in 2040
November 20, 2018 - Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network
November 20, 2018 - The plug and play time-resolved spectrometer from PicoQuant
November 20, 2018 - Breakthrough technology offers new hope to people with glaucoma, retinitis and macular degeneration
November 20, 2018 - New report highlights key focus areas to help cancer screening realize its full potential
November 20, 2018 - International experts to discuss strategies to maintain spatial orientation in old age
November 20, 2018 - Scientists discover new inhibitor that decreases lung inflammation
November 20, 2018 - Participation project calls for relaxing research ban on germline interventions
November 20, 2018 - Karyopharm’s Selinexor Receives Fast Track Designation from FDA for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma
November 20, 2018 - Arthritis by the Numbers: Book of Trusted Facts & Figures
November 20, 2018 - Drug homing method helps rethink Parkinson’s
November 20, 2018 - AHF commends the passage of global AIDS funding in the House, calls for swift approval
November 20, 2018 - The search for new psychiatric disorder treatments
November 20, 2018 - New research offers hope for simpler way to diagnose and treat cancer
November 20, 2018 - Study sheds light on the infection mechanism of influenza virus
November 20, 2018 - Storage failures of eggs and embryos gain a new perspective
November 20, 2018 - Buyers of short-term health plans: Wise or shortsighted?
November 20, 2018 - Study indicates that frogs in virus-exposed groups breed at young age
November 20, 2018 - FDA Alerts Health Care Professionals and Patients Not To Use Sterile Drug Products from Pharm D Solutions
November 20, 2018 - Asthma may contribute to childhood obesity epidemic
November 20, 2018 - Researchers to explore the enigmatic role of unstructured protein in regulating circadian function
November 20, 2018 - Many patients with adenomas do not receive colonoscopy within recommended time frame
November 20, 2018 - Drug used to treat PTSD does not reduce suicidal thinking, may worsen nightmares and insomnia
November 20, 2018 - In-person social contact may offer protection against depression and PTSD symptoms
November 20, 2018 - Routine HCV testing in correctional facilities can best identify and treat disease, say researchers
November 20, 2018 - Molecular DNA analysis could facilitate more accurate prognosis, treatment of aggressive brain tumors
November 20, 2018 - Breast Cancer Recurrence Rate Not Up With Autologous Fat Transfer
November 20, 2018 - Beta 2 Microglobulin (B2M) Tumor Marker Test: MedlinePlus Lab Test Information
November 20, 2018 - Could bariatric surgery make men more virile?
November 20, 2018 - Urine test to check if patients take their medications will save the NHS money, say researchers
November 20, 2018 - Study reveals impact of residual inflammatory risk on clinical outcomes after PCI
November 20, 2018 - RNAi therapy shown to alleviate preeclampsia
November 20, 2018 - Replacement of dysfunctional microglia has therapeutic potential for neurodegenerative diseases
November 20, 2018 - Forming 3D Neuronal Models of the Brain
November 20, 2018 - Shoulder ultrasounds could be used to predict diabetes
November 20, 2018 - SGLT2 Inhibitors for Diabetes Linked to Increased Risk for Amputation
November 20, 2018 - Stem cell transplant cements Arizona men’s father-son bond
November 20, 2018 - Scientists try to develop portable systems that can quickly produce biologics on demand
November 20, 2018 - Automating Data Capture and Image Analysis in Continuous Experiments
November 20, 2018 - New drug shows promise for treating people with peanut allergy
November 20, 2018 - Researchers develop novel mouse model to study immunomodulatory therapies
November 20, 2018 - “Britain must not go backward on antibiotic controls to appease US trade deals” – Jim Moseley, CEO of Red Tractor
November 20, 2018 - Widespread errors in ‘proofreading’ cause inherited blindness
November 20, 2018 - Reaping the benefits of living longer
November 20, 2018 - New Program Hopes to Make Early Detection and Treatment of ALS a Reality
November 19, 2018 - Artificial bone-like substance mimics the way real bone grows at atomic level
November 19, 2018 - FDA Grants Orphan Drug Designation To RGX-181 Gene Therapy For The Treatment Of CLN2 Form Of Batten Disease
November 19, 2018 - Systemic mastocytosis – Genetics Home Reference
November 19, 2018 - Eye trauma secondary to falls in older adults increasing
November 19, 2018 - Empowering women in India to improve their health: A Q&A
November 19, 2018 - Researchers have trained a computer to analyze breast cancer images and classify tumors
November 19, 2018 - New glucose binding molecule could be key to better metabolic control for diabetics
November 19, 2018 - Biologists uncover novel genetic control of lipid maintenance and its potential connection to lifespan
November 19, 2018 - Warmer winters may set scene for higher rates of violent crimes
November 19, 2018 - Personalized program of physical exercise effective in reversing functional decline in the elderly
November 19, 2018 - Acacia Pharma Resubmits Barhemsys New Drug Application
November 19, 2018 - PDL1 (Immunotherapy) Tests: MedlinePlus Lab Test Information
November 19, 2018 - Transforming pregnancy research with a smartphone app
November 19, 2018 - Stanford Medicine magazine explores how digital technology is changing health care
November 19, 2018 - Vision impairments may increase risk of falls in older adults
November 19, 2018 - Concomitant use of sleeping pills and opioids found to prevalent among people with Alzheimer’s disease
November 19, 2018 - Marijuana prevention programs should focus on promoting mental wellbeing of youth
November 19, 2018 - New report calls for greater awareness and emphasis on scale and impact of atrial fibrillation
November 19, 2018 - In throes of turkey salmonella outbreak, don’t invite illness to your table
November 19, 2018 - UK health policies should be redesigned to become more accessible for men
November 19, 2018 - Short Interpregnancy Intervals Tied to Adverse Outcome Risk
November 19, 2018 - New mothers’ breastfeeding pain can affect infant health
November 19, 2018 - Stanford Medicine magazine reports on ways digital technology is transforming health care | News Center
November 19, 2018 - Human drugs alter cricket personality
November 19, 2018 - Insilico Medicine to introduce ‘Cure a disease in a year’ program at Biodata World Congress 2018
November 19, 2018 - Experts debate over whether gut or brain is more important in regulating appetite
November 19, 2018 - Playing on fear and fun, hospitals follow pharma in direct-to-consumer advertising
November 19, 2018 - 2PG Company receives grant to develop sensitive, low-cost molecular diagnostic tests for tuberculosis
November 19, 2018 - Low-Carb Diets May Work By Boosting Calorie Burn
November 19, 2018 - Key molecule responsible for learning and memory discovered
November 19, 2018 - New blood test developed for early diagnosis of ovarian cancer
November 19, 2018 - Researchers identify molecule to fight myotubular myopathy
After opioid overdose, only 30 percent get medicine to treat addiction

After opioid overdose, only 30 percent get medicine to treat addiction

image_pdfDownload PDFimage_print

More than 115 Americans die every day of opioid overdose. Many more survive thanks to the antidote medication, naloxone. But a study out Monday finds that just 3 in 10 patients revived by an EMT or in an emergency room received the follow-up medication known to avoid another life-threatening event.

The study, published in the Annals of Internal Medicine, followed 17,568 patients who overdosed on opioids between 2012 and 2014 in Massachusetts. It looked at survival rates over time and whether patients received medicines that treat addiction.

Of the patients who did receive medication, 3,022 adults were on buprenorphine, known by the brand name Suboxone, and 2,040 patients were on methadone. The Suboxone group had a 40 percent lower death rate after one year, as compared to those who did not receive any medication. The results for methadone were even stronger: a 60 percent lower death rate.

About 6 percent of patients were on the opioid blocker, naltrexone (brand name Vivitrol) but often for just one month. They were no more likely to be alive after a year than those who were not offered or did not take a medication.

“The stunning finding here is that we have effective treatments for people who survive an overdose but only 3 in 10 are getting those medications,” said Dr. Marc LaRochelle, lead author on the study.

For some perspective, LaRochelle mentions the routine recommendation that patients who’ve had another life-threatening event, a heart attack, take aspirin.

“The mortality reduction we see with these drugs is similar to giving someone who suffers a heart attack aspirin. It’s one of the most effective treatments we have in medicine,” said LaRochelle, who’s a primary care physician and researcher at the Grayken Center for Addiction at Boston Medical Center.

But he points to a a big difference — 98 percent of people in this country get aspirin for a heart attack.

The gap in care is similar to findings from a U.K. study, but this Boston-based research is the first to follow U.S. patients seen in a hospital or by EMTs, said Dr. Nora Volkow, who directs the National Institute on Drug Abuse.

“A great part of the tragedy of this opioid crisis is that, unlike in previous such crises America has seen, we now possess effective treatment strategies that could address it and save lives,” Volkow wrote in an accompanying editorial. “Yet tens of thousands of people die each year because they have not received these treatments.”

To understand why so few patients get methadone or buprenorphine, one need only cross the street from Boston Medical Center where LaRochelle works. There are clinics that offer both drugs, and there’s a needle-exchange, focused on harm reduction for drug users who are still in active addiction. In the early morning hours, some men and women were lining up for their daily dose of methadone, others were starting their day with a shot of heroin or fentanyl and two men were trading crumpled bills for two blue tablets.

Scott, a 38-year-old from Lowell, Mass., leans against a building. He says he’s overdosed three or four times, but wasn’t offered Suboxone until after his third overdose.

“The problem is, a lot of these doctors don’t want to prescribe anything like that after the person has an overdose because they feel like they’ll abuse the medicine,” Scott said. We’re only using first names for people may still be buying illegal drugs.

Scott admits he has abused Suboxone. It and methadone are both opioid-based medications. Taken as directed they block cravings for something stronger without making the patient high.

But with Suboxone, “a lot of people that get prescribed it, take a lot more than they’re supposed to and that gives you a high or they sell them to get money,” Scott said.

Others layer alcohol or other medications for a different kind of high. Few doctors are trained to or have experience managing such complex addictions. Scott said he “understands why they’re reluctant to prescribe stuff” like Suboxone.

Sometimes it’s the patient who is reluctant to start medication-assisted treatment.

“There’s a perception that people aren’t quote-unquote ‘clean’ unless they’re abstinent from all substances and that plays into keeping people away from medication treatment, which is the most effective treatment,” said Aubri, who is on methadone and says it works.

But Aubri said the way methadone is delivered is demeaning. Unlike Suboxone, which patients can get from a primary care doctor, during routine medical care, methadone is tightly controlled, typically only available at designated clinics.

“It feels like a jail,” Aubri said. “There’s literal bars across the gates that don’t open til a certain time. There’s security guards. No one wants to be there. The only reason people go is because they need it.”

Many communities continue to reject applications to open methadone clinics. Patients in rural areas often drive more than an hour each way to get their daily dose. The obstacles to care contribute to a feeling among many opioid addiction patients that doctors and hospitals just don’t want to help.

“They treat us like crap,” said Deana, as she hugs her husband Phill. “We’re not like this because we’re bad people, you know.”

Deana and Phill have an endless stream of stories about feeling mistreated in hospitals. But Phill is having the opposite experience now, taking Suboxone, through a clinic at the Boston Health Care for the Homeless Program.

“They give you the counseling, the therapy. It’s like a family,” said Phill, pausing as a ambulance wails by. “They make you feel welcomed and loved and give you that sense of hope that I can have a drug-free life. I don’t have to use.”

Many things have changed since the 2012-2014 period of this study. A growing number of physicians are allowed to prescribe buprenorphine and the number of patients they can manage has increased from 100 to 275. Hospitals are starting to prescribe buprenorphine within the emergency room and opening walk-in clinics for follow-up care. In Boston, there’s a mobile van that takes buprenorphine prescribing to the streets.

LaRochelle worries that patients, as seen in this study, are still not staying on treatment for more than a few months and are losing prime years of their lives. Some 66 percent of people in the study were under the age of 45.

“We need to reevaluate how we’re providing the care and make sure we can keep people there when they’re there,” LaRochelle said.

Even at just 3 in 10 patients, Massachusetts was likely offering better opioid medication treatment than many states as of 2014. That’s because 97 percent of the state’s residents have health insurance, the highest rate in the country. In many parts of the U.S., it’s difficult to find someone who will prescribe a patient methadone or buprenorphine.

“We just still have overwhelming stigma for patients with the disease of addiction,” said Sarah Melton, a professor of pharmacy practice at East Tennessee State University.

Volkow of NIDA is alarmed by one other finding. Thirty-four percent of patients receive at least one prescription for an opioid and 26 percent were prescribed a benzodiazepine during the 12 months after their overdose.

“This indicates that guidelines cautioning against prescribing opioids and their co-use with benzodiazepines are not being followed,” Volkow wrote.

This story is part of a partnership that includes WBUR, NPR and Kaiser Health News.

Martha Bebinger, WBUR: [email protected], @mbebinger

Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Tagged with:

About author

Related Articles